tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Jubilant Pharmova to Transfer Unclaimed Dividends to IEPF

Story Highlights
  • Jubilant Pharmova informs shareholders about transferring unclaimed dividends to IEPF.
  • Shareholders urged to claim dividends to prevent transfer of shares to IEPF by November 1, 2025.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Jubilant Pharmova to Transfer Unclaimed Dividends to IEPF

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Jubilant Pharmova Limited ( (IN:JUBLPHARMA) ) has shared an update.

Jubilant Pharmova Limited has notified its shareholders about the transfer of unclaimed dividends and equity shares to the Investor Education and Protection Fund (IEPF) as per regulatory requirements. Shareholders with unclaimed dividends for seven consecutive years, starting from the financial year 2017-18, are urged to claim their dividends before the due transfer date of November 1, 2025, to avoid their shares being moved to the IEPF. This action underscores the company’s adherence to compliance regulations and impacts shareholders who have not claimed their dividends, potentially affecting their equity holdings.

More about Jubilant Pharmova Limited

Jubilant Pharmova Limited operates in the pharmaceutical industry, focusing on the development, manufacturing, and distribution of a wide range of pharmaceutical products. The company is known for its contributions to healthcare and pharmaceuticals, serving various markets with its diverse product portfolio.

Average Trading Volume: 17,175

Technical Sentiment Signal: Buy

Current Market Cap: 190B INR

For a thorough assessment of JUBLPHARMA stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1